Log In
Print
BCIQ
Print
Print this Print this
 

Ranexa, ranolazine (formerly Latixa)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionSelective late sodium current blocker
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today